SAN DIEGO, April 16, 2012 /PRNewswire/ -- Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization (CDMO) supporting the pharmaceutical industry, announced that it has expanded its existing liquid encapsulation capabilities by purchasing a Qualicaps® FS3 Automated Liquid Filling and Banding System. The addition of the Qualicaps® FS3 unit to Pharmatek's manufacturing capabilities increases overall efficiency at the Phase 2 production scale.
"The Qualicaps® FS3 unit increases our scale of capsule filling, and it also has a number of other features that increase the quality of this particular dosage form," stated Kevin Rosenthal, Director of Manufacturing for Pharmatek. "It has a robust gelatin band sealing technology that allows a quick visual check of seal integrity. The Qualicaps® FS3 unit also has a heated hopper system for handling a broad range of liquid viscosities, including semi-solid and other BCS Class II formulations."
The Qualicaps® FS3 unit is equipped with an inert gas purge system and unique capsule lifting feature, allowing for the handling of oxygen sensitive drug products. The inert gas purge system presents warmed air, or inert gas, into the headspace of the capsule, minimizing process defects and thus increasing the overall product yield. The FS3 liquid filling and banding system is configured to handle clear or colored banding and gelatin or HPMC capsules ranging in sizes from 4 to 00.
"The acquisition of the Qualicaps® FS3 unit increases our cGMP liquid capsule filling rate substantially. This increased rate allows Pharmatek to be more cost effective for larger scale liquid encapsulation projects. More efficient production of larger scale batches helps us to better support our clients through their late-stage Phase 2B clinical studies," stated Jeffrey Bibbs, CEO and CSO of Pharmatek.
For a complete listing of Pharmatek's manufacturing equipment and capabilities, please visit: www.pharmatek.com/gmp-manufacturing.html.
About Pharmatek Laboratories, Inc.
Pharmatek Laboratories, Inc. is a premier pharmaceutical contract development and manufacturing organization providing full-service pharmaceutical chemistry product development for the biotech and pharmaceutical industries. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, cGMP manufacturing, stability storage and testing, and cytotoxic and high-potency drug development.
Statements contained in this media release which are not historical facts may constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion. The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry, Pharmatek Formulation Screening, Pharmatek University and PTEK U are all property of Pharmatek Laboratories, Inc. Additional information about Pharmatek Laboratories may be obtained at the Web site http://www.pharmatek.com or by calling 858-805-6383.
Kimberly Scholz, Marketing Associate
Pharmatek Laboratories, Inc.
(858) 805-6383 x284
SOURCE Pharmatek Laboratories, Inc.